Connor Iapoce

Lead SODIUM-HF investigator Justin Ezekowitz provides insight into the trial and why dietary interventions may still be important for heart failure care.

The majority of patients with HFrEF and RAASi-related hyperkalemia achieved optimal doses of RAASi when treated with patiromer.

No difference in the primary outcome was observed between those randomized to influenza vaccine compared to placebo.

In a new interview from ACC 2022, Florian Rader, MD discusses the potential of the new medication for HCM and the need to monitor safety signals over the long-term.

Desai discusses the potential long-term effects of mavacamten and what it could mean for a patient population with HCM.

Findings from SODIUM-HF suggest strategies to reduce dietary sodium intake to less than 1500 mg daily were not more effective than usual care in reducing hospitalization risk.

Findings from VALOR-HCM suggest more data is needed to assess the durability of improvement in septal reduction therapy eligibility over longer time periods.

New research suggests a consistent risk reduction of empagliflozin may be theorized independent of region or race categories.

Hospitalized HFrEF patients had a higher rate of the cardiovascular death or a worsening heart failure event than outpatients

Dr. Jabbour discusses unmet needs in diabetes care and starting insulin therapy.

Team-based care shows the reduction of multiple risk factors, attainment of multiple treatment targets, and empowerment among high-risk patients with DKD.

Female academic ophthalmologists were paid a mean of $50,300 less than male peers.

Dr. Bailey highlights the innovative nature of the procedure and breaks down the process at his institution.

The resolution of excess central retinal thickness in response to anti-VEGF therapy and the treatment burden were additionally similar between the 2 groups.

The therapy is indicated for conditions associated with hypogonadism in adult males.

In a population aged 70 years and older, a remote history of VT was associated with an increased risk of VT independent of other factors.

The lens is added to a patient’s eye through a quick surgical procedure with no removal of corneal tissue and can be removed by a doctor if desired.

Severe and level 2 hypoglycemia has continued to occur in individuals with type 1 diabetes and high hypoglycemia risks despite technological advancements.

Large variations were observed in the transition between monotherapy and dual combination therapy for hypertension across countries and demographic group.

Strategies to improve enrollment of underrepresented populations were centered on study design and site selection, community engagement, and changing the research paradigm.

Greater increases were observed among members of racial and ethnic minority groups, with the highest increase among non-Hispanic Black individuals.

A favorable lifestyle is associated with a lower risk of coronary artery disease in carriers and noncarriers of FH variants.

Dr. Bajona highlights the patient risks of HCM, new advances in treatment options, and the importance of screening efforts.

Children exposed and not exposed to neonatal hypoglycemia did not have significant differences in rates of low educational performance at 9 to 10 years old.

Higher BMI in overweight category at midlife was associated with a greater burden of overall and CVD morbidity, as well as higher health care costs in older adulthood.

A user fee goal date of August 17, 2022 has been assigned to teplizumab.

Alcohol use was additionally associated with worse fibrosis, but no interaction was noted between the two risk factors.

Deep learning analyses of photographic images and other test results in clinical trials may reduce cost and improve the consistency and accuracy of end point assessments.

AI-based screening for ROP may be more cost-effective than traditional screening modalities, but depends significantly on the added cost of AI.

Dr. Lee highlights the process of identifying CTEPH and the patient population, as well as the available treatments for the condition.